Fulgent Genetics (FLGT) Total Current Liabilities (2015 - 2026)

Fulgent Genetics has reported Total Current Liabilities for 12 years, with the latest figure at $71.8 million in Q2 2026.

• Quarterly Total Current Liabilities rose 0.59% year-over-year to $71.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $71.8 million (up 0.59% YoY) and the FY2025 annual result came in at $85.0 million, up 16.55% from the prior year.
• Total Current Liabilities eased to $71.8 million in Q2 2026 per FLGT's latest filing, from $90.1 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $141.7 million in Q1 2022 and troughed at $61.4 million in Q3 2023.
• A 5-year average of $83.1 million and a median of $74.9 million in 2024 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2023 and 2026: Total Current Liabilities plunged 49.17% in 2023, then soared 36.74% in 2026.
• Over 5 years, Total Current Liabilities stood at $88.1 million in 2022, then declined by 17.13% to $73.0 million in 2023, then fell by 0.16% to $72.9 million in 2024, then increased by 16.55% to $85.0 million in 2025, then declined by 15.55% to $71.8 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $71.8 million, $90.1 million, and $85.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.